Next Century Growth Investors’s Eli Lilly LLY Stock Holding History

Next Century Growth Investors’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-6,307	Closed	-$5.59M	–	138
2024 Q3	$5.59M	Sell	6,307 -541	-8%	-$486K	0.45%	73
2024 Q2	$6.2M	Sell	6,848 -1,110	-14%	-$888K	0.51%	57
2024 Q1	$6.19M	Buy	7,958 +106	+1%	+$75.4K	0.54%	54
2023 Q4	$4.58M	Sell	7,852 -18	-0.2%	-$10.5K	0.45%	64
2023 Q3	$4.23M	Hold	7,870	–	–	0.46%	59
2023 Q2	$3.69M	Buy	7,870 +754	+11%	+$316K	0.36%	69
2023 Q1	$2.44M	Buy	7,116 +4,362	+158%	+$1.47M	0.27%	76
2022 Q4	$1.01M	Buy	+2,754	New	+$976K	0.12%	91

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Next Century Growth Investors's LLY Position: Q4 2024 in Review

Next Century Growth Investors sold out of Eli Lilly (LLY) in Q4 2024, closing a stake of 6,307 shares — an estimated $5.59M sold.

Next Century Growth Investors first reported a position in LLY in Q4 2022 and held it in 8 quarters. The position peaked at $6.2M in Q2 2024. 3,906 funds tracked by Wall St. Rank hold LLY as of Q4 2024.

Next Century Growth Investors reported no remaining Eli Lilly position as of Q4 2024 after selling out during the quarter.
Next Century Growth Investors sold 6,307 Eli Lilly shares in Q4 2024, an estimated $5.59M.
Next Century Growth Investors first reported a position in Eli Lilly in Q4 2022 and held it in 8 quarters.
Next Century Growth Investors's Eli Lilly position peaked at $6.2M in Q2 2024.
3,906 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2024.

Based on Next Century Growth Investors's 13F filing for Q4 2024, filed 13 Feb 2025.